Logo image of JBS

JBS NV-A (JBS) Stock Fundamental Analysis

USA - NYSE:JBS - NL0015002J37 - Common Stock

15.19 USD
-0.11 (-0.72%)
Last: 9/23/2025, 3:49:03 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to JBS. JBS was compared to 89 industry peers in the Food Products industry. There are concerns on the financial health of JBS while its profitability can be described as average. JBS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

JBS had positive earnings in the past year.
JBS Yearly Net Income VS EBIT VS OCF VS FCFJBS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

With a decent Return On Assets value of 5.10%, JBS is doing good in the industry, outperforming 70.79% of the companies in the same industry.
With an excellent Return On Equity value of 25.34%, JBS belongs to the best of the industry, outperforming 94.38% of the companies in the same industry.
JBS has a better Return On Invested Capital (11.18%) than 85.39% of its industry peers.
JBS had an Average Return On Invested Capital over the past 3 years of 8.84%. This is significantly below the industry average of 27.85%.
The last Return On Invested Capital (11.18%) for JBS is above the 3 year average (8.84%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.1%
ROE 25.34%
ROIC 11.18%
ROA(3y)3.8%
ROA(5y)N/A
ROE(3y)18.79%
ROE(5y)N/A
ROIC(3y)8.84%
ROIC(5y)N/A
JBS Yearly ROA, ROE, ROICJBS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 2.65%, JBS is in line with its industry, outperforming 56.18% of the companies in the same industry.
JBS has a better Operating Margin (6.03%) than 61.80% of its industry peers.
With a Gross Margin value of 14.56%, JBS perfoms like the industry average, outperforming 40.45% of the companies in the same industry.
Industry RankSector Rank
OM 6.03%
PM (TTM) 2.65%
GM 14.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JBS Yearly Profit, Operating, Gross MarginsJBS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 5 10 15

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so JBS is creating value.
Compared to 1 year ago, JBS has about the same amount of shares outstanding.
Compared to 1 year ago, JBS has a worse debt to assets ratio.
JBS Yearly Shares OutstandingJBS Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 200M 400M 600M 800M 1B
JBS Yearly Total Debt VS Total AssetsJBS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

JBS has an Altman-Z score of 3.05. This indicates that JBS is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.05, JBS is doing good in the industry, outperforming 65.17% of the companies in the same industry.
JBS has a Debt/Equity ratio of 2.39. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.39, JBS is not doing good in the industry: 88.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.39
Debt/FCF N/A
Altman-Z 3.05
ROIC/WACC2.09
WACC5.35%
JBS Yearly LT Debt VS Equity VS FCFJBS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 1.54 indicates that JBS should not have too much problems paying its short term obligations.
JBS has a Current ratio of 1.54. This is comparable to the rest of the industry: JBS outperforms 52.81% of its industry peers.
JBS has a Quick Ratio of 1.54. This is a bad value and indicates that JBS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.76, JBS is doing worse than 61.80% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 0.76
JBS Yearly Current Assets VS Current LiabilitesJBS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5B 10B 15B

More info and screens

3

3. Growth

3.1 Past

JBS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 988.51%, which is quite impressive.
The Revenue has been growing slightly by 5.85% in the past year.
EPS 1Y (TTM)988.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)5.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

JBS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.49% yearly.
Based on estimates for the next years, JBS will show a small growth in Revenue. The Revenue will grow by 6.06% on average per year.
EPS Next Y22.46%
EPS Next 2Y-0.46%
EPS Next 3Y8.49%
EPS Next 5YN/A
Revenue Next Year11.6%
Revenue Next 2Y6.79%
Revenue Next 3Y6.06%
Revenue Next 5YN/A

3.3 Evolution

JBS Yearly Revenue VS EstimatesJBS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
JBS Yearly EPS VS EstimatesJBS Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.5 1 1.5 2

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.91, the valuation of JBS can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of JBS indicates a rather cheap valuation: JBS is cheaper than 89.89% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, JBS is valued rather cheaply.
The Price/Forward Earnings ratio is 9.62, which indicates a very decent valuation of JBS.
Based on the Price/Forward Earnings ratio, JBS is valued cheaper than 92.13% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of JBS to the average of the S&P500 Index (22.87), we can say JBS is valued rather cheaply.
Industry RankSector Rank
PE 7.91
Fwd PE 9.62
JBS Price Earnings VS Forward Price EarningsJBS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JBS is valued cheaper than 84.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.1
JBS Per share dataJBS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

JBS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y-0.46%
EPS Next 3Y8.49%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 12.92%, JBS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.11, JBS pays a better dividend. On top of this JBS pays more dividend than 96.63% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, JBS pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.92%

5.2 History

JBS does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

DPN/A
EPS Next 2Y-0.46%
EPS Next 3Y8.49%
JBS Yearly Income VS Free CF VS DividendJBS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2022 2023 2024 0 1B 2B

More info and screens

JBS NV-A

NYSE:JBS (9/23/2025, 3:49:03 PM)

15.19

-0.11 (-0.72%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-13 2025-11-13
Inst Owners0.35%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.85B
Analysts82.67
Price Target20.83 (37.13%)
Short Float %6.61%
Short Ratio5
Dividend
Industry RankSector Rank
Dividend Yield 12.92%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.41%
PT rev (3m)N/A
EPS NQ rev (1m)-0.68%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)1.99%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.37%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.91
Fwd PE 9.62
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B 2
P/tB 25.03
EV/EBITDA 5.1
EPS(TTM)1.92
EY12.64%
EPS(NY)1.58
Fwd EY10.39%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS72.52
BVpS7.59
TBVpS0.61
PEG (NY)0.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.1%
ROE 25.34%
ROCE 15.41%
ROIC 11.18%
ROICexc 12.19%
ROICexgc 16.66%
OM 6.03%
PM (TTM) 2.65%
GM 14.56%
FCFM N/A
ROA(3y)3.8%
ROA(5y)N/A
ROE(3y)18.79%
ROE(5y)N/A
ROIC(3y)8.84%
ROIC(5y)N/A
ROICexc(3y)10.32%
ROICexc(5y)N/A
ROICexgc(3y)14.74%
ROICexgc(5y)N/A
ROCE(3y)12.18%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity 2.39
Debt/FCF N/A
Debt/EBITDA 2.86
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 0.76
Altman-Z 3.05
F-ScoreN/A
WACC5.35%
ROIC/WACC2.09
Cap/Depr(3y)84.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.34%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)988.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y22.46%
EPS Next 2Y-0.46%
EPS Next 3Y8.49%
EPS Next 5YN/A
Revenue 1Y (TTM)5.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year11.6%
Revenue Next 2Y6.79%
Revenue Next 3Y6.06%
Revenue Next 5YN/A
EBIT growth 1Y284.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.87%
EBIT Next 3Y14.06%
EBIT Next 5YN/A
FCF growth 1Y215.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y77.8%
OCF growth 3YN/A
OCF growth 5YN/A